Retracted: Reversal of vecuronium with neostigmine in patients with diabetes mellitus : Reversal of neuromuscular blockade in diabetics (Anaesthesia, (2004), 59, 8, (750-754), 10.1111/j.1365-2044.2004.03833.x);Reversal of vecuronium with neostigmine in patients with diabetes mellitus

Anaesthesia

Volumn 59, Issue 8, 2004, Pages 750-754

  Saitoh, Y ^a   Hattori, H ^b   Sanbe, N ^b   Nakajima, H ^b   Akatu, M ^b   Murakawa, M ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticholinesterase drugs; neostigmine; Diabetes mellitus; Monitoring; intra operative; Neuromuscular blocking agents; vecuronium

Indexed keywords

ATROPINE; DIAZEPAM; FENTANYL; GLUCOSE; NEOSTIGMINE; OXYGEN; PROPOFOL; SEVOFLURANE; VECURONIUM; CHOLINESTERASE INHIBITOR; NEUROMUSCULAR BLOCKING AGENT;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; ELECTROMYOGRAPHY; FEMALE; GENERAL ANESTHESIA; GLUCOSE BLOOD LEVEL; HUMAN; LUNG FUNCTION; MALE; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BREATHING; DRUG ANTAGONISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; CHOLINESTERASE INHIBITORS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RESPIRATION; VECURONIUM BROMIDE;

EID: 4344642006     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14241     Document Type: Erratum

References (32)

1. Saitoh Y, Kaneda K, Hattori H, Nakajima H, Murakawa M. Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus. British Journal of Anaesthesia 2003; 90: 480-6.
2. Woolf AL, Malins JM. Changes in the intramuscular nerve endings in diabetic neuropathy: a biopsy study. Journal of Pathology and Bacteriology 1957; 73: 316-8.
3. Lawrence DG, Locke S. Motor nerve conduction velocity in diabetes. Archives of Neurology 1961; 5: 483-9.
4. Skillman TG, Johnson EW, Hamwi GJ, Driskill HJ. Motor nerve conduction velocity in diabetes mellitus. Diabetes 1961; 10: 46-51.
5. Abu-Shakra SR, Cornblath DR, Avila OL, et al. Conduction block in diabetic neuropathy. Muscle and Nerve 1991; 14: 858-62.
6. Lamontagne A, Buchthal F. Electrophysiological studies in diabetic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry 1970; 33: 442-52.
7. Eady JL, Cobbs KF. Diabetic muscle infarction. Journal of the Southern Orthopaedic Association 1997; 6: 250-5.
8. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachusetts General Hospital, Case 21-1987. Presentation of Case. New England Journal of Medicine 1987; 316: 1326-35.
9. Rocca PV, Alloway JA, Nashel DJ. Diabetic muscle infarction. Seminars in Arthritis and Rheumatism 1993; 22: 280-7.
10. Slyke MAV, Ostrov BE. MRI evaluation of diabetic muscle infarction. Magnetic Resonance Imaging 1995; 13: 325-9.
11. Nesto RW, Zarich SW, Jacoby RM, Kamalesh M. Heart disease in diabetes. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus, 13th edn. Philadelphia: Lea & Febiger, 1994: 844-5.
12. Viby-Mogensen J, Engbæk J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiologica Scandinavica 1996; 40: 59-74.
13. Donati F. Onset of action of relaxants. Canadian Journal of Anesthesia 1988; 35: S52-8.
14. Baurain MJ, Hoton F, D'Hollander AA, Cantraine FR. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium? British Journal of Anaesthesia 1996; 77: 496-9.
15. Baurain MJ, D'Hollander AA, Melot C, Dernovoi BS, Barvais L. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 1991; 74: 474-8.
16. Dernovoi B, Agoston S, Barvais L, Baurain M, Lefebvre R, D'Hollander A. Neostigmine antagonism of vecuronium paralysis during fentanyl, halothane, isoflurane, and enflurane anesthesia. Anesthesiology 1987; 66: 698-701.
17. Baurain MJ, Dernovoi BS, D'Hollander AA, Hennart DA, Cantraine FR. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block. Acta Anaesthesiologica Scandinavica 1996; 40: 574-8.
18. Ali HH, Kitz RJ. Evaluation of recovery from nondepolarizing neuromuscular block, using a digital neuromuscular transmission analyzer. Preliminary report. Anesthesia and Analgesia 1973; 52: 740-5.
19. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997; 86: 765-71.
20. Boulbou MS, Gourgoulianis KI, Petinaki EA, Klisiaris VK, Maniatis AN, Molyvdas PA. Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus. Canadian Respiratory Journal 2003; 10: 259-64.
21. Saitoh Y, Toyooka H, Amaha K. Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neuroleptanaesthesia. British Journal of Anaesthesia 1993; 70: 402-4.
22. Saitoh Y, Toyooka H, Amaha K. Relationship between post-tetanic twitch and single twitch response after administration of vecuronium. British Journal of Anaesthesia 1993; 71: 443-4.
23. Saitoh Y, Kaneda K, Toyooka H, Amaha K. Post-tetanic count and single twitch height at the onset of reflex movement after administration of vecuronium under different types of anaesthesia. British Journal of Anaesthesia 1994; 72: 688-90.
24. Baker T, Aguero A, Stanec A, Lowndes HE. Prejunctional effects of vecuronium in the cat. Anesthesiology 1986; 65: 480-4.
25. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block. Journal of Clinical Anesthesia 1995; 7: 635-9.
26. Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesthesia and Analgesia 1999; 89: 333-9.
27. Kirkegaard-Nielsen H, Severinsen IK, Pedersen HS, Lindholm P. Factors predicting atracurium reversal time. Acta Anaesthesiologica Scandinavica 1999; 43: 834-41.
28. Goldhill DR, Carter JA, Suresh D, Whitehead JP, Flynn PJ. Antagonism of atracurium with neostigmine. Effect of dose on speed of recovery. Anaesthesia 1991; 46: 496-9.
29. Bennett PH. Definition, diagnosis, and classification of diabetes mellitus and impaired glucose tolerance. Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus, 13th edn. Philadelphia: Lea & Febiger 1994, 193-200.
30. Horton JN. Anaesthesia and diabetes. In: Nimmo WS, Rowbotham DJ, Smith G, eds. Anaesthesia, 2nd edn. Oxford: Blackwell Scientific Publications, 1994: 1077-90.
31. Morita T, Tsukagoshi H, Sugaya T, Saito S, Sato H, Fujita T. Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia. Anesthesia and Analgesia 1995; 80: 1175-80.
32. Kopman AF. The relationship of evoked electromyographic and mechanical responses following atracurium in humans. Anesthesiology 1985; 63: 208-11.